ORIGINAL RESEARCH article
Front. Cell. Infect. Microbiol.
Sec. Bacteria and Host
Targeting Helicobacter pylori enzymes using Viscum album L. extract: in silico molecular docking and in vitro study
Provisionally accepted- 1Universitatea din Oradea Facultatea de Medicina si Farmacie, Oradea, Romania
- 2Zagazig University Faculty of Pharmacy, Zagazig, Egypt
- 3Zagazig University Faculty of Medicine, Zagazig, Egypt
- 4Kafrelsheikh University Faculty of Pharmacy, Kafr El-Shaikh, Egypt
- 5University of Oradea, Oradea, Romania
- 6University of Tabuk, Tabuk, Saudi Arabia
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Viscum album L. (mistletoe) is a hemiparasitic plant known for its wide range of bioactive compounds, including phenolics, flavonoids, and lectins, which contribute to its diverse pharmacological properties. In the present study, we focused on identifying and quantifying the phenolic compounds present in V. album L. leaf extracts and evaluating their potential as inhibitors of key Helicobacter pylori enzymes through both in silico and in vitro approaches. Using molecular docking, we assessed the binding affinity and stability of selected mistletoe's phytochemicals with specific H. pylori targets, including peptide deformylase, shikimate pathway enzymes, and urease. Additionally, to complement the computational findings, we conducted an in vitro assay to evaluate the anti-urease activity of the crude V. album L. extract against the urease activity of Proteus mirabilis. The extract demonstrated significant inhibitory activity, indicating its potential as a natural urease inhibitor at a concentration of 0.0125 mg/mL, leading to a marked reduction in urease-mediated crystal formation in artificial urine. Furthermore, the extract exhibited broad-spectrum anti virulence effects by suppressing biofilm formation in Staphylococcus aureus and Escherichia coli, and inhibiting protease activity in S. aureus and P. aeruginosa. Together, these findings highlight V. album phenolics as promising dual-action natural inhibitors that not only target essential metabolic enzymes but also attenuate virulence factors critical for pathogenesis. This integrated strategy positions V. album as a strong candidate for the development of plant-based therapeutics against multidrug-resistant pathogens with possible applications in the treatment of H. pylori-related gastrointestinal disorders.
Keywords: H. pylori, Mistletoe, molecular docking, phenolic compounds, urease inhibitor
Received: 22 Aug 2025; Accepted: 09 Dec 2025.
Copyright: © 2025 Cardos, Danila, Yahya, Seleem, Mosbah, Shaldam, Vicas, Metwally and Cavalu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Catalina Danila
Galal Yahya
Simona Cavalu
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
